Proprotein convertase subtilisin/kexin type 9 (mRNA and protein) expression is elevated in the frontal cortices of AD patients together with other biomarkers of AD suggesting a role for PCSK9 in disease progression (Picard et al., 2019). This evidence concerns the gene PCSK9 and Alzheimer disease.